Assessment of the role of high-density lipoproteins and their immunomodulatory activity in systemic lupus erythematosus immunopathology

• Published in: Lupus science & medicine Vol. 11; no. 2; p. e001242
• Main Authors: Pérez-Ocampo, Julián, Vergara-Serpa, Oscar, Velásquez-Franco, Carlos Jaime, Taborda, Natalia A, Yassin, Lina M, Hernandez, Juan C
• Format: Journal Article
• Language: English
• Published: England Lupus Foundation of America 25-07-2024; BMJ Publishing Group LTD; BMJ Publishing Group
• Subjects: Apoptosis; Atherosclerosis; Cholesterol; Chronic illnesses; Cytokines; Disease; Epidemiology; Gene expression; High density lipoprotein; Immunology; Immunology and Inflammation; Inflammation; Kinases; Lipids; Lipoproteins; Lupus; Original Research; Patients; Proteins; Systemic Lupus Erythematosus; Tumor necrosis factor-TNF; United States > US; Massachusetts; California; Systemic Lupus Erythematosus; Lipids; Inflammation; Cytokines; Atherosclerosis
• ISSN: 2053-8790; 2053-8790
• DOI: 10.1136/lupus-2024-001242

ObjectiveTo explore the potential associations between high-density lipoprotein (HDL) levels and inflammasome components in the context of systemic lupus erythematosus (SLE).MethodsA cross-sectional study was conducted. A group of 50 patients with SLE and 50 healthy controls matched by sex and similar age ranges were enrolled. Serum HDL cholesterol (HDL-C) and C reactive protein (CRP) levels were quantified. Serum cytokine levels, including IL-1β and IL-6, were determined by ELISA. The gene expression of inflammasome-related genes in peripheral blood mononuclear cells was measured by quantitative real-time PCR.ResultsHDL-C levels were lower in the patients with SLE (p<0.05), and on segregation according to disease activity, those with active SLE had the lowest HDL-C levels. Patients with SLE presented higher concentrations of the serum inflammatory cytokines IL-1β and IL-6 (p<0.0001) but similar levels of CRP to those in controls. A similar scenario was observed for the gene expression of inflammasome components, where all the evaluated markers were significantly upregulated in the SLE population. These results revealed significant negative correlations between HDL levels and disease activity, serum IL-6 and IL-1β levels and the mRNA expression of NLRP3, IL-1β and IL-18. In addition, significant positive correlations were found between disease activity and serum IL-1β and between disease activity and the mRNA expression of IL-18, and interestingly, significant positive correlations were also observed between active SLE and serum IL-1β and the mRNA expression of NLRP3.ConclusionOur results suggest that HDL is essential for SLE beyond atherosclerosis and is related to inflammation regulation, possibly mediated by inflammasome immunomodulation.